Products

Diabetes is personal. For more than 30 million people in over 100 countries, embecta is the trusted choice.

Background Image
tabs dropdown arrow

Closer to more people living with diabetes

We have been one of the leaders in insulin delivery for nearly 100 years. Today, through our insulin-delivery products, we touch an estimated 30 million people living with diabetes in over 100 countries.²

For nearly 100 years, we’ve been making insulin delivery simpler and more comfortable for people around the world. We know your diabetes experience is unique to you, and — no matter what your treatment plan looks like — you should never have to face diabetes alone. With a singular focus on improving the lives of people living with diabetes, embecta offers a wide variety of insulin-delivery devices and comprehensive care resources to best fit your needs:

 

  • Shorter pen needles, for example 4mm, are the recommended needle length for patients and for all injection sites.*

 

  • Insulin syringe portfolio offering that accommodates various patient needs

 

  • A variety of educational resources help with your day-to-day management of diabetes


* American Diabetes Association. Standards of Medical Care in Diabetes—2020. DiabetesCare.2020;43(suppl 1):S1-S212.

  • Pen Needles 

    Our products are diligently designed to enable people who are living with diabetes to benefit from comfortable, effective diabetes care

    Learn More

    forward-arrow
  • Insulin Syringes

    Portfolio of needle lengths and barrel sizes designed to help to meet the needs of people with diabetes

    Learn More

    forward-arrow

References

  1. Whooley S, Briskin T, Gibney MA, Blank LR, Berube J, Pflug BK. Evaluating the user performance and experience with a re-engineered 4mm × 32G pen needle: a randomised trial with similar length/gauge needles. Diabetes Ther. 2019;10(2):697-712.

  2. Data on file. embecta market model.  2021